{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:29:26Z","timestamp":1748280566994,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6-7","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA138599"],"award-info":[{"award-number":["R01-CA138599"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA186193","U01-CA174706"],"award-info":[{"award-number":["R01-CA186193","U01-CA174706"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention Research Institute of Texas","doi-asserted-by":"crossref","award":["RR160005"],"award-info":[{"award-number":["RR160005"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Math. Biol."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00285-022-01828-x","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T04:32:41Z","timestamp":1668054761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-703X","authenticated-orcid":false,"given":"Anna Claudia M.","family":"Resende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto A. B. F.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina C.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Yankeelov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"1828_CR1","doi-asserted-by":"publisher","unstructured":"Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB (2005) The liposomal formulation of doxorubicin. In: Liposomes, Methods in Enzymology. https:\/\/doi.org\/10.1016\/S0076-6879(05)91004-5","DOI":"10.1016\/S0076-6879(05)91004-5"},{"issue":"1","key":"1828_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","volume":"15","author":"KO Alfarouk","year":"2015","unstructured":"Alfarouk KO, Stock CM, Taylor S, Walsh M, Muddathir AK, Verduzco D, Bashir AHH, Mohammed OY, Elhassan GO, Harguindey S, Reshkin SJ, Ibrahim ME, Rauch C (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int 15(1):71. https:\/\/doi.org\/10.1186\/s12935-015-0221-1","journal-title":"Cancer Cell Int"},{"key":"1828_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrc4029","volume":"15","author":"PM Altrock","year":"2015","unstructured":"Altrock PM, Liu LL, Michor F (2015) The mathematics of cancer: integrating quantitative models. Nat Rev Cancer 15:730\u2013745. https:\/\/doi.org\/10.1038\/nrc4029","journal-title":"Nat Rev Cancer"},{"key":"1828_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-74075-1","volume-title":"Model based inference in the life sciences: A primer on evidence","author":"DR Anderson","year":"2008","unstructured":"Anderson DR (2008) Model based inference in the life sciences: A primer on evidence. Springer, New York"},{"key":"1828_CR5","unstructured":"ATCC: American Type Culture Collection. University Boulevard, Manassas, VA, USA. http:\/\/www.atcc.org"},{"issue":"1","key":"1828_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cjs.10045","volume":"38","author":"L Bornn","year":"2010","unstructured":"Bornn L, Doucet A, Gottardo R (2010) An efficient computational approach for prior sensitivity analysis and cross-validation. Canadian J Stat \/ La Revue Canadienne de Statistique 38(1):47\u201364. https:\/\/doi.org\/10.1002\/cjs.10045","journal-title":"Canadian J Stat \/ La Revue Canadienne de Statistique"},{"key":"1828_CR7","volume-title":"Model selection and multimodel inference - a practical information-theoretic approach","author":"KP Burnham","year":"2002","unstructured":"Burnham KP, Anderson DR (2002) Model selection and multimodel inference - a practical information-theoretic approach, 2nd edn. Springer-Verlag, New York","edition":"2"},{"issue":"2","key":"1828_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0049124104268644","volume":"33","author":"KP Burnham","year":"2004","unstructured":"Burnham KP, Anderson DR (2004) Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res 33(2):261\u2013304. https:\/\/doi.org\/10.1177\/0049124104268644","journal-title":"Sociol Methods Res"},{"key":"1828_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/9783110288537.279","volume":"12","author":"HM Byrne","year":"2012","unstructured":"Byrne HM (2012) Mathematical biomedicine and modeling avascular tumor growth. Math Life Sci 12:279\u2013312","journal-title":"Math Life Sci"},{"key":"1828_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gecco.2017.e00365","volume":"13","author":"EJ Chapman","year":"2018","unstructured":"Chapman EJ, Byron CJ (2018) The flexible application of carrying capacity in ecology. Global Ecol Conserv 13:e00365. https:\/\/doi.org\/10.1016\/j.gecco.2017.e00365","journal-title":"Global Ecol Conserv"},{"key":"1828_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/BD-2010-0307","volume":"32","author":"KJ Chavez","year":"2010","unstructured":"Chavez KJ, Garimella SV, Lipkowitz S (2010) Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer. Breast Dis 32:35\u201348. https:\/\/doi.org\/10.3233\/BD-2010-0307","journal-title":"Breast Dis"},{"issue":"25","key":"1828_CR12","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1200\/JCO.2008.21.0807","volume":"27","author":"L Claret","year":"2009","unstructured":"Claret L, Girard P, Hoff PM, Cutsem EV, Zuideveld KP, Jorga K, Fagerberg J, Bruno R (2009) Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics. J Clin Oncol 27(25):4103\u20134108. https:\/\/doi.org\/10.1200\/JCO.2008.21.0807","journal-title":"J Clin Oncol"},{"key":"1828_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/BCTT.S69488","volume":"8","author":"J Collignon","year":"2016","unstructured":"Collignon J, Lousberg L, Schroeder H, Jerusalem G (2016) Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer: Targets Therapy 8:93\u2013107. https:\/\/doi.org\/10.2147\/BCTT.S69488","journal-title":"Breast Cancer: Targets Therapy"},{"key":"1828_CR14","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X, Cheng H, Bai Z, Li J (2017) Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 8:3131\u20133141. https:\/\/doi.org\/10.7150\/jca.18457","journal-title":"J Cancer"},{"key":"1828_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00090","volume":"1","author":"B Denard","year":"2012","unstructured":"Denard B, Lee C, Ye J (2012) Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1. Elife 1:e00090. https:\/\/doi.org\/10.7554\/eLife.00090","journal-title":"Elife"},{"issue":"2","key":"1828_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/10705511.2016.1250640","volume":"24","author":"S Depaoli","year":"2017","unstructured":"Depaoli S, Yang Y, Felt J (2017) Using bayesian statistics to model uncertainty in mixture models: A sensitivity analysis of priors. Struct Equ Modeling 24(2):198\u2013215. https:\/\/doi.org\/10.1080\/10705511.2016.1250640","journal-title":"Struct Equ Modeling"},{"key":"1828_CR17","doi-asserted-by":"publisher","unstructured":"Estacio K, Prudencio E, Malaya N, Vohra M, McDougall D (2016) The QUESO library, user\u2019s manual . https:\/\/doi.org\/10.48550\/ARXIV.1611.07521","DOI":"10.48550\/ARXIV.1611.07521"},{"key":"1828_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jcp.2015.03.071","volume":"295","author":"K Farrell","year":"2015","unstructured":"Farrell K, Oden JT, Faghihi D (2015) A Bayesian framework for adaptive selection, calibration, and validation of coarse-grained models of atomistic systems. J Comput Phys 295:189\u2013208. https:\/\/doi.org\/10.1016\/j.jcp.2015.03.071","journal-title":"J Comput Phys"},{"issue":"7","key":"1828_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005030","volume":"12","author":"F Fr\u00f6hlich","year":"2016","unstructured":"Fr\u00f6hlich F, Thomas P, Kazeroonian A, Theis FJ, Grima R, Hasenaue J (2016) Inference for stochastic chemical kinetics using moment equations and system size expansion. PLoS Comput Biol 12(7):e1005030. https:\/\/doi.org\/10.1371\/journal.pcbi.1005030","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"1828_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K (2019) Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov 9(2):176\u2013198. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1177","journal-title":"Cancer Discov"},{"issue":"7","key":"1828_CR21","first-page":"3417","volume":"43","author":"RF Greene","year":"1983","unstructured":"Greene RF, Collins JM, Jenkins JF, Speyer JL, Myers CE (1983) Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res 43(7):3417\u20133421","journal-title":"Cancer Res"},{"issue":"6","key":"1828_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nmeth.3852","volume":"13","author":"LA Harris","year":"2016","unstructured":"Harris LA, Frick PL, Garbett SP, Hardeman KN, Paudel BB, Lopez CF, Quaranta V, Tyson DR (2016) An unbiased metric of antiproliferative drug effect in vitro. Nat Methods 13(6):497\u2013500. https:\/\/doi.org\/10.1038\/nmeth.3852","journal-title":"Nat Methods"},{"key":"1828_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000455820","volume":"12","author":"M Hubalek","year":"2017","unstructured":"Hubalek M, Czech T, M\u00fcller H (2017) Biological subtypes of triple-negative breast cancer. Breast Care 12:8\u201314. https:\/\/doi.org\/10.1159\/000455820","journal-title":"Breast Care"},{"key":"1828_CR24","unstructured":"ImageJ: Image processing and analysis in Java. https:\/\/imagej.nih.gov\/ij\/"},{"key":"1828_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051314","author":"AM Jarrett","year":"2020","unstructured":"Jarrett AM, Faghihi D, Hormuth DA, Lima EABF, Virostko J, Biros G, Patt D, Yankeelov TE (2020) Optimal control theory for personalized therapeutic regimens in oncology: ackground, history, challenges, and opportunities. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9051314","journal-title":"J Clin Med"},{"issue":"8","key":"1828_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000399","volume":"17","author":"KE Johnson","year":"2019","unstructured":"Johnson KE, Howard G, Mo W, Strasser MK, Lima EABF, Huang S, Brock A (2019) Cancer cell population growth kinetics at low densities deviate from the exponential growth model and suggest an Allee effect. PLoS Biol 17(8):e3000399. https:\/\/doi.org\/10.1371\/journal.pbio.3000399","journal-title":"PLoS Biol"},{"issue":"1","key":"1828_CR27","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/abb09c","volume":"18","author":"KE Johnson","year":"2020","unstructured":"Johnson KE, Howard GR, Morgan D, Brenner EA, Gardner AL, Durrett RE, Mo W, Al\u2019Khafaji A, Sontag ED, Jarrett AM, Yankeelov TE, Brock A (2020) Integrating transcriptomics and bulk time course data into a mathematical framework to describe and predict therapeutic resistance in cancer. Phys Biol 18(1):016001. https:\/\/doi.org\/10.1088\/1478-3975\/abb09c","journal-title":"Phys Biol"},{"key":"1828_CR28","volume-title":"Information criteria and statistical modeling","author":"S Konishi","year":"2007","unstructured":"Konishi S, Kitagawa G (2007) Information criteria and statistical modeling, 1st edn. Springer Publishing Company, Incorporated","edition":"1"},{"key":"1828_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/456409","author":"J Lao","year":"2013","unstructured":"Lao J, Madani J, Pu\u00e9rtolas T, \u00c1lvarez M, Hern\u00e1ndez A, Pazo-Cid R, Artal \u00c1, Torres AA (2013) Liposomal doxorubicin in the treatment of breast cancer patients: a review. J Drug Delivery. https:\/\/doi.org\/10.1155\/2013\/456409","journal-title":"J Drug Delivery"},{"key":"1828_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovi\u0107 B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA (2016) Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS ONE 11:e0157368. https:\/\/doi.org\/10.1371\/journal.pone.0157368","journal-title":"PLoS ONE"},{"issue":"13","key":"1828_CR31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1142\/S0218202514500304","volume":"24","author":"EABF Lima","year":"2014","unstructured":"Lima EABF, Oden JT, Almeida RC (2014) A hybrid ten-species phase-field model of tumor growth. Math Models Methods Appl Sci 24(13):2569\u20132599. https:\/\/doi.org\/10.1142\/S0218202514500304","journal-title":"Math Models Methods Appl Sci"},{"key":"1828_CR32","doi-asserted-by":"publisher","unstructured":"Lima EABF, Oden JT, Wohlmuth B, Shahmoradi A II, D.A.H., Yankeelov, T.E., Scarabosio, L., Horger, T. (2017) Selection and validation of predictive models of radiation effects on tumor growth based on noninvasive imaging data. Comput Methods Appl Mech Eng 327:277\u2013305. https:\/\/doi.org\/10.1016\/j.cma.2017.08.009","DOI":"10.1016\/j.cma.2017.08.009"},{"key":"1828_CR33","doi-asserted-by":"crossref","unstructured":"Loyola-Vargas, V.M., V\u00e1zquez-Flota, F. (eds.): Plant Cell Culture Protocols, 2nd edn. No. 318 in Methods in Molecular Biology. Humana Press (2006)","DOI":"10.1385\/1592599591"},{"key":"1828_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jtbi.2012.02.002","volume":"301","author":"P Macklin","year":"2012","unstructured":"Macklin P, Edgerton ME, Thompson AM, Cristini V (2012) Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 301:122\u2013140. https:\/\/doi.org\/10.1016\/j.jtbi.2012.02.002","journal-title":"J Theor Biol"},{"key":"1828_CR35","doi-asserted-by":"publisher","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B (2017) The different mechanisms of cancer drug resistance: a brief review. Adv Pharma Bull 7(3):339\u2013348. https:\/\/doi.org\/10.15171\/apb.2017.041","DOI":"10.15171\/apb.2017.041"},{"issue":"6","key":"1828_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2022.02.005","volume":"8","author":"D Mathur","year":"2022","unstructured":"Mathur D, Barnett E, Scher HI, Xavier JB (2022) Optimizing the future: how mathematical models inform treatment schedules for cancer. Trends Cancer 8(6):506\u2013516. https:\/\/doi.org\/10.1016\/j.trecan.2022.02.005","journal-title":"Trends Cancer"},{"key":"1828_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05902-z.5725","volume":"7","author":"MT McKenna","year":"2017","unstructured":"McKenna MT, Weis JA, Barnes SL, Tyson DR, Miga MI, Quaranta V, Yankeelov TE (2017) A predictive mathematical modeling approach for the study of doxorubicin treatment in triple negative breast cancer. Sci Rep 7:1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-05902-z.5725","journal-title":"Sci Rep"},{"key":"1828_CR38","doi-asserted-by":"publisher","unstructured":"Moore H (2018) How to mathematically optimize drug regimens using optimal control. J Pharmacokinet Pharmacodyn 45:127\u2013137. https:\/\/doi.org\/10.1007\/s10928-018-9568-y","DOI":"10.1007\/s10928-018-9568-y"},{"key":"1828_CR39","doi-asserted-by":"publisher","unstructured":"Oden JT, Babus\u030cka, I., Faghihi, D. (2017) Predictive computational science: computer predictions in the presence of uncertainty. Am Cancer Soc. https:\/\/doi.org\/10.1002\/9781119176817.ecm2101","DOI":"10.1002\/9781119176817.ecm2101"},{"issue":"3","key":"1828_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1142\/S0218202510004313","volume":"20","author":"JT Oden","year":"2010","unstructured":"Oden JT, Hawkins A, Prudhomme S (2010) General diffuse-interface theories and an approach to predictive tumor growth modeling. Math Models Methods Appl Sci 20(3):477\u2013517. https:\/\/doi.org\/10.1142\/S0218202510004313","journal-title":"Math Models Methods Appl Sci"},{"issue":"7","key":"1828_CR41","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1142\/S0218202513500103","volume":"23","author":"JT Oden","year":"2013","unstructured":"Oden JT, Prudencio EE, Hawkins-Daarud A (2013) Selection and assessment of phenomenological models of tumor growth. Math Models Methods Appl Sci 23(7):1309\u20131338. https:\/\/doi.org\/10.1142\/S0218202513500103","journal-title":"Math Models Methods Appl Sci"},{"key":"1828_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bby043","author":"F Pappalardo","year":"2018","unstructured":"Pappalardo F, Russo G, Tshinanu FM, Viceconti M (2018) In silico clinical trials: concepts and early adoptions. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bby043","journal-title":"Brief Bioinform"},{"key":"1828_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.00387","volume":"1","author":"AG Patel","year":"2011","unstructured":"Patel AG, Kaufmann SH (2011) How does doxorubicin work? Elife 1:1\u20133. https:\/\/doi.org\/10.7554\/eLife.00387","journal-title":"Elife"},{"key":"1828_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0076-6879(09)67002-6","volume":"467","author":"V Quaranta","year":"2009","unstructured":"Quaranta V, Tyson DR, Garbett SP, Weidow B, Harris MP, Georgescu W (2009) Trait variability of cancer cells quantified by high-content automated microscopy of single cells. Methods Enzymol 467:23\u201357. https:\/\/doi.org\/10.1016\/S0076-6879(09)67002-6","journal-title":"Methods Enzymol"},{"key":"1828_CR45","unstructured":"Queso: Quantification of Uncertainty for Estimation, Simulation and Optimization. https:\/\/github.com\/libqueso\/queso"},{"key":"1828_CR46","doi-asserted-by":"publisher","unstructured":"Renu K, V.G., A., P.B., T.P., Arunachalam, S. (2018) Molecular mechanism of doxorubicin-induced cardiomyopathy. Eur J Pharmacol 818:241\u2013253. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.043","DOI":"10.1016\/j.ejphar.2017.10.043"},{"key":"1828_CR47","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.20230362","author":"ACM Resende","year":"2022","unstructured":"Resende ACM, Lima EABF, Almeida RC, McKenna MT, Yankeelov TE (2022) Model Selection. Doxorubicin & TNBC. https:\/\/doi.org\/10.6084\/m9.figshare.20230362","journal-title":"Doxorubicin & TNBC"},{"key":"1828_CR48","doi-asserted-by":"publisher","unstructured":"Ribba B, Holford NH, Magni P, Troc\u00f3niz I, Gueorguieva I, Girard P, Sarr C, Elishmereni M, Kloft C, Friberg LE (2014) A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis. CPT: Pharmacomet Syst Pharmacol 3(5):113. https:\/\/doi.org\/10.1038\/psp.2014.12","DOI":"10.1038\/psp.2014.12"},{"issue":"4","key":"1828_CR49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","volume":"10","author":"S Rivankar","year":"2014","unstructured":"Rivankar S (2014) An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther 10(4):853\u2013858. https:\/\/doi.org\/10.4103\/0973-1482.139267","journal-title":"J Cancer Res Ther"},{"issue":"311","key":"1828_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-12-311","volume":"12","author":"A Stein","year":"2012","unstructured":"Stein A, Wang W, Carter AA, Chiparus O, Hollaender N, Kim H, Motzer RJ, Sarr C (2012) Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial. BMC Cancer 12(311):1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-12-311","journal-title":"BMC Cancer"},{"key":"1828_CR51","doi-asserted-by":"publisher","DOI":"10.1137\/1.9780898717921","volume-title":"Inverse problem theory and methods for model parameter estimation","author":"A Tarantola","year":"2005","unstructured":"Tarantola A (2005) Inverse problem theory and methods for model parameter estimation. SIAM, Philadelphia"},{"issue":"9","key":"1828_CR52","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth.2138","volume":"9","author":"DR Tyson","year":"2012","unstructured":"Tyson DR, Garbett SP, Frick PL, Quaranta V (2012) Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data. Nat Methods 9(9):923\u2013928. https:\/\/doi.org\/10.1038\/nmeth.2138","journal-title":"Nat Methods"},{"issue":"19","key":"1828_CR53","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.3390\/cancers13195009","volume":"13","author":"S Vasudevan","year":"2021","unstructured":"Vasudevan S, Adejumobi IA, Alkhatib H, Roy Chowdhury S, Stefansky S, Rubinstein AM, Kravchenko-Balasha N (2021) Drug-induced resistance and phenotypic switch in triple-negative breast cancer can be controlled via resolution and targeting of individualized signaling signatures. Cancers 13(19):5009. https:\/\/doi.org\/10.3390\/cancers13195009","journal-title":"Cancers"},{"key":"1828_CR54","doi-asserted-by":"publisher","unstructured":"Yang F, Teves SS, Kemp CJ, Henikoff S (2014) Doxorubicin, DNA torsion, and chromatin dynamics. Biochimica et Biophysica Acta (BBA) - Rev Cancer 1845(1):84\u201389. https:\/\/doi.org\/10.1016\/j.bbcan.2013.12.002","DOI":"10.1016\/j.bbcan.2013.12.002"},{"issue":"9","key":"1828_CR55","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1007\/s10439-016-1691-6","volume":"44","author":"TE Yankeelov","year":"2016","unstructured":"Yankeelov TE, An G, Saut O, Luebeck EG, Popel AS, Ribba B, Vicini P, Zhou X, Weis JA, Ye K, Genin GM (2016) Multi-scale modeling in clinical oncology: opportunities and barriers to success. Ann Biomed Eng 44(9):2626\u20132641. https:\/\/doi.org\/10.1007\/s10439-016-1691-6","journal-title":"Ann Biomed Eng"}],"container-title":["Journal of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-022-01828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00285-022-01828-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00285-022-01828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:14:29Z","timestamp":1669835669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00285-022-01828-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":55,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1007\/s00285-022-01828-x","relation":{},"ISSN":["0303-6812","1432-1416"],"issn-type":[{"type":"print","value":"0303-6812"},{"type":"electronic","value":"1432-1416"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"65"}}